PATENT CLAIM ANALYSIS

Application Number: 15877042
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "009320"]

Abstract:
The present application concerns multimodal composite products for imaging, in particular for diagnostic imaging, and optionally for therapy, in particular composite products which are capable of being used as contrast agents, in particular in magnetic resonance imaging (MRI), and/or in imaging techniques such as, for example, in optical imaging, in the optical detection of oxidants, in positron emission tomography (PET), in tomodensitometry (TDM) and/or in ultrasound imaging, and optionally simultaneously for use in therapy. These products are based on a particle comprising or consisting of a portion provided with a contrast agent activity and/or a paramagnetic activity, and a portion provided with a luminescent activity and optionally an oxidant detection activity.

Claim (Index 18):
The method of  claim 1 , wherein element L is excited directly in the visible.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 2.01538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15390106', '11627273', '14492749', '11601011', '14426036']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7288040973218454
- 35 USC 102 Novelty (BERT): 0.5216905924549465
- Combined Prediction Score: 0.7080927468351554
- Mean Citation Score: 201.701188
- Max Citation Score: 210.2953
- Similarity Product: 99.30476363643706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test